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POLYMERASE CHAIN REACTION: ADVANTAGES AND DRAWBACKS 
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To confirm or to rule out the presence of one specific pathogenic agent in a tissue 
sample is the most common application of polymerase chain reaction (PCR).  
 
BASICS TO GET STARTED: 
PCR uses short segments of nucleotides, called primers. The sequences of these 
primers are complementary to the sequences of the target (microbe nucleic acids). 
The primers serve as templates upon which a new DNA molecule can be 
synthesized. They may be of 
variable length but are 
usually 15-30bp long. The 
primers are added to a 
solution of containing a DNA 
polymerase, each of the four 
nucleotides and a source of 
DNA containing the target 
sequence. The solution is 
heated to denaturate the 
DNA (separate into its two 
strands), then cooled to let 
primers bind to 
complementary regions on the target DNA.  The 
solution is subsequently heated again to promote 
DNA extension (addition of nucleotides to the 
primers ends). The product is consequently a 
sequence of DNA delimited by the two primers and 
strictly identical to the target DNA. The solution will be submitted to 25 to 40 cycles 
(amplification). The whole reaction results in an accumulation of millions of copies of 
the target DNA. Confirmation of the correctly sized amplified DNA product is usually 
carried out by agarose gel electrophoresis. The picture on the right is one typical 
example of the end-point PCR: two different sets of primers were used (PAPF and 
CP4) and three sampüles were tested (22,24,39). With first set of primers, all 
samples were negative while, with the second one, sample 24 was positive.  
 
MATERIAL 
 
PCR is a powerful tool to amplify minute amounts of nucleic acids. Due to its 
unprecedented sensitivity, the method has become an essential diagnostic and 
research tool for infectious dermatology. Additionally, PCR can be used on all tissues 
or samples (fresh tissues, paraffin-embedded tissues, blood, feces etc…). It is also 
possible to analyze samples of poor conditions because only relatively short intact 
sequences of DNA are required. Archival materials can consequently be used for 
retrospective studies. In this latter case, however, amplification depends on the 
conservation of the target DNA. It has, for example, been demonstrated that DNA 
could be spoiled by long-stay in formalin and that amplification subsequently failed.  
 
PCR HAS SOME LIMITATIONS…. 
 
PCR is not only a very sensitive technique but also a very specific one: The primers 
are usually directly complementary to the target sequence and DNA can only be 
amplified if the matching target DNA-primer is adequate. In fact, as primers are 
directly complementary to target DNA, amplification only occurs if the target is 
exactly or closely related to the DNA sequence of the expected causative agent. For 
example, primers designed to amplify canine oral papillomavirus DNA will probably 
not amplify the DNA of another canine papillomavirus. PCR demands that sequence 
information be available for at least a part of the DNA that is to be amplified.  
Interpreting the clinical relevance of a positive PCR amplification can also be 
challenging. In fact some extremely sensitive nested PCR detect even 0.05 viral 
copy per cell. The presence of such trace amounts of DNA does not indicate a 
productive infection but probably a latent or clinically non-relevant infection. For this 
reason, one must interpret cautiously some PCR results. 
Last but not least, PCR does not allow localization of the nucleic acids. It is 
consequently not possible to differentiate a clinical infection from a contamination. It 
has, for example been shown, that papillomavirus DNA can be amplified from 
virtually each sample of normal human skin. But the detection rate is much lower 
when the stratum corneum of these samples is removed. This indicates that most of 
these papillomavirus are probably contaminant.  
 
BUT IT IS NOT THAT BAD: THERE IS ALWAYS A SOLUTION! 
PCR cannot amplify RNA… 
As PCR cannot amplify RNA, detection of RNA is carried out through reverse-
transcriptase PCR (RT-PCR). The enzyme reverse transcriptase allows synthesis 
of cDNA from a RNA template. PCR is subsequently carried out, using cDNA as 
target DNA. 
 
PCR only amplifies specific targets… 
To circumvent this drawback degenerate or consensus primers can be designed: 
Such primers allow the amplification of nucleic acids of multiple related infectious 
agents (Some degenerated primers are able to amplify nucleic acids of up to 70 
human papillomaviruses, for example).  
 
PCR amplifies only a very limited part of the genome… 
That is true but it is also possible, in some instances, to carry out the reaction with 
several set of primers: Multiplex PCR consists of multiple primer sets within a single 
PCR mixture to produce amplicons of varying sizes that are specific to different DNA 
sequences. By targeting multiple genes at once, additional information may be 
gained from a single test-run that otherwise would require several times the reagents 
and more time to perform. Annealing temperatures for each of the primer sets must 
be optimized to work correctly within a single reaction, and amplicon sizes. That is, 
their base pair length should be different enough to form distinct bands when 
visualized by gel electrophoresis.  
 
PCR may sometimes not be specific enough… 
That is the reason why nested PCR were developed! In fact, nested PCR increases 
the specificity of DNA amplification, by reducing background due to non-specific 
amplification of DNA. Two sets of primers are used in two successive PCRs. In the 
first reaction, one pair of primers is used to generate DNA products, which besides 
the intended target, may still consist of non-specifically amplified DNA fragments. 
The product(s) are then used in a second PCR with a set of primers whose binding 
sites are completely or partially different from and located 3' of each of the primers 
used in the first reaction. Nested PCR is often more successful in specifically 
amplifying long DNA fragments than conventional PCR, but it requires more detailed 
knowledge of the target sequences. 
 
PCR is not quantitative… 
But it can be… Real-time PCR (qPCR; RT should be reserved for Reverse 
Transcriptase and Real Time should be noted Q for quantitative!) has been 
developed to estimate nucleic acids concentration within the samples. qPCR is used 
to measure the quantity of a target sequence (commonly in real-time). It 
quantitatively measures starting amounts of DNA, cDNA, or RNA. Quantitative PCR 
is commonly used to determine whether a DNA sequence is present in a sample and 
the number of its copies in the sample. Quantitative PCR has a very high degree of 
precision. Quantitative PCR methods use fluorescent dyes, such as Sybr Green, 
EvaGreen or fluorophore-containing DNA probes, such as TaqMan, to measure the 
amount of amplified product in real time. In the last few years, in 
example, such procedure were used in two different studies to 
assess the expression of thymic stromal lymphopoietin (TSLP) 
and fillagrin, respectively, in skin samples retrieved from dogs 
with atopic dermatitis. For such studies a references gene 
should be used, whose expression is stable and consistent in 
canine skin. In the picture on the right, one should imagine that A is the curve of the 
reference gene and B the curve of the studied genes: as the exponential phase of 
the reaction begin with less cycles (in this case, n:10) than for the reference gene 
(n:15), we can conclude that the studied gene is expressed more than the reference 
gene. If the expression of the reference gene is known, expression of the studied can 
be computed. 
 
It is not possible to know where the DNA was in the sample… 
In situ hybridization can be regarded as a combination of PCR and 
immunochemistry and allows cellular localization of the target DNA. Basically, PCR 
is used to generate dye-associated primers 
that will serve subsequently for the 
immunochemistry. We have used this tool to 
demonstrate that viral DNA was present in 
the koilocytes of early stages of penis carcinomas in horses. On the left part of the 
picture, we can see the koilocytes and on the right part, we see that these koilocytes 
harbor the viral DNA. 
 
PCR FROM BENCH TO BEDSIDE: WONDERFUL BUT…. BE CAREFUL! 
 
As mentioned above, PCR is a wonderful tool for research but also for daily 
diagnosis. One should however be aware of one possible pitfall: the sensitivity of the 
method. As already said, some very sensitive PCR settings may be able to identify 
as few as one genome copy within 100 cells! It is very unlikely that these few 
microorganisms may cause any damage to the host but… the test is positive! One 
should consequently interpret PCR results cautiously. Exactly like the IgE serology 
tests that identify sensitization (and not allergy!), PCR identifies infection, but does 
not say anything on the actual link between this infection and the clinical signs. Let’s 
take the example of leishmaniasis! 
Before 2000, most authors agreed that the prevalence of the disease was from 1 to 
15% in endemic areas of Europe. But, as soon as PCR studies began, data 
changed. It was suddenly obvious that the great majority, if not all, dogs living in 
endemic areas were infected. But only some of them were seropositive and few 
presented with clinical signs!  That is the reason why PCR is NOT a good test to 
assess whether leishmania infection explain the clinical signs of one specific dog. 
The gold standard to answer this question remains the detection of leishmania-
specific IgG! 
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